The primary endpoint for CUV156 is listed as October. The yearly report a few weeks ago said they are doing analysis and finishing treatment for some patients. So that means at least several weeks from then. So basically anytime between now and end of October I would expect a readout.
OTC Novel product range, page-5
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.55 |
Change
0.000(0.00%) |
Mkt cap ! $725.1M | |||
| Open | High | Low | Value | Volume |
| $14.60 | $14.60 | $14.32 | $164.8K | 11.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55 | $14.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.55 | 80 | 5 |
View Market Depth
| Last trade - 11.25am 10/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |